×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EKTAY – elekta b shs unsp/adr (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EKTAY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
10/3
04:26 am
ektay
Radiotherapy Market Analysis and Forecast 2018-2030: China and India Witnessing Substantial Market Growth Due to Their Large Population Base and Efforts to Improve Cancer Treatment Facilities [Yahoo! Finance]
Low
Report
Radiotherapy Market Analysis and Forecast 2018-2030: China and India Witnessing Substantial Market Growth Due to Their Large Population Base and Efforts to Improve Cancer Treatment Facilities [Yahoo! Finance]
9/6
11:09 am
ektay
Should Value Investors Buy Elekta (EKTAY) Stock? [Yahoo! Finance]
Low
Report
Should Value Investors Buy Elekta (EKTAY) Stock? [Yahoo! Finance]
8/28
10:57 am
ektay
Elekta AB (publ) (EKTAF) Q1 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Elekta AB (publ) (EKTAF) Q1 2025 Earnings Call Transcript [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
10/23
ELEKTA AB/ADR (OTCMKTS: EKTAY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock.
7.5%
2/21 ELEKTA AB/ADR (OTCMKTS: EKTAY) was downgraded by analysts at Pareto Securities from a "buy" rating to a "hold" rating. 5.8%
4/28 ELEKTA AB/ADR (OTCMKTS: EKTAY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.4%
2/28 ELEKTA AB/ADR (OTCMKTS: EKTAY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 3.6%
1/17 ELEKTA AB/ADR (OTCMKTS: EKTAY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 3.6%
2/26 Elekta Named one of the World's Most Ethical Companies by Ethisphere for the Second Time 3.5%
12/16 FDA Approves Diffusion-Weighted Images for Elekta Unity, Expanding Options for Assessment During Therapy 3.2%
4/23 ELEKTA AB/ADR (OTCMKTS: EKTAY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.50 price target on the stock. 2.5%
1/15 China's HEDY Group Acquires 10 Elekta Cancer Treatment Systems 2.0%
11/25 Form F-6EF Elekta AB / ADR Filed by: JPMorgan Chase Bank, N.A. - ADR Depositary 1.4%
2/21 ELEKTA AB/ADR (OTCMKTS: EKTAY) was downgraded by analysts at Pareto Securities from a "buy" rating to a "hold" rating. 5.8%
4/28 ELEKTA AB/ADR (OTCMKTS: EKTAY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.4%
2/28 ELEKTA AB/ADR (OTCMKTS: EKTAY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 3.6%
1/17 ELEKTA AB/ADR (OTCMKTS: EKTAY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 3.6%
2/26 Elekta Named one of the World's Most Ethical Companies by Ethisphere for the Second Time 3.5%
12/16 FDA Approves Diffusion-Weighted Images for Elekta Unity, Expanding Options for Assessment During Therapy 3.2%
4/23 ELEKTA AB/ADR (OTCMKTS: EKTAY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.50 price target on the stock. 2.5%
1/15 China's HEDY Group Acquires 10 Elekta Cancer Treatment Systems 2.0%
11/25 Form F-6EF Elekta AB / ADR Filed by: JPMorgan Chase Bank, N.A. - ADR Depositary 1.4%
TOP News Decliners
11/14
ELEKTA AB/ADR (OTCMKTS: EKTAY) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating.
-11.2%
7/12 Elekta to Demonstrate Leadership in Precision Radiation Medicine at AAPM with Launch of new QA Portfolio -3.6%
11/28 Elekta AB (publ) (EKTAF) CEO Richard Hausmann on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] -3.3%
8/22 Elekta AB (EKTAF) CEO Richard Hausmann on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] -1.5%
5/6 ELEKTA AB/ADR (OTCMKTS: EKTAY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -1.4%
4/22 ELEKTA AB/ADR (OTCMKTS: EKTAY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -1.1%
9/5 Elekta Announces Exclusive Agreement With DOSIsoft for Distribution of Key Patient-specific QA Solutions -1.0%
8/27 ELEKTA AB/ADR (OTCMKTS: EKTAY) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -0.6%
7/11 University Hospital Tübingen Delivers 1,000th Fraction With its Elekta Unity MR-Linac -0.6%
1/30 Switzerland's Hôpital Riviera-Chablais Treats its First Patient With Elekta Unity MR-Linac -0.5%
7/12 Elekta to Demonstrate Leadership in Precision Radiation Medicine at AAPM with Launch of new QA Portfolio -3.6%
11/28 Elekta AB (publ) (EKTAF) CEO Richard Hausmann on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] -3.3%
8/22 Elekta AB (EKTAF) CEO Richard Hausmann on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] -1.5%
5/6 ELEKTA AB/ADR (OTCMKTS: EKTAY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -1.4%
4/22 ELEKTA AB/ADR (OTCMKTS: EKTAY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -1.1%
9/5 Elekta Announces Exclusive Agreement With DOSIsoft for Distribution of Key Patient-specific QA Solutions -1.0%
8/27 ELEKTA AB/ADR (OTCMKTS: EKTAY) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -0.6%
7/11 University Hospital Tübingen Delivers 1,000th Fraction With its Elekta Unity MR-Linac -0.6%
1/30 Switzerland's Hôpital Riviera-Chablais Treats its First Patient With Elekta Unity MR-Linac -0.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: